242697 ⎘
MEDICAMENT FOR THE TREATMENT OF VIRAL SKIN AND TUMOUR DISEASES
#2Medicament for the treatment of viral skin and tumour diseases
#34'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION
#4Anti-infective methods and systems for treating pathogen-induced disordered tissues
#5Medicament for the treatment of viral skin and tumour diseases
#6Nucleoside Analogs in Combination Therapy of Herpes Simplex Infections
#7Powders for reconstitution
#84′-substituted nucleoside derivatives as inhibitors of HCV RNA replication
#94′-substituted nucleoside derivatives as inhibitors of HCV RNA replication
#10Nucleoside analogs in combination therapy of herpes simplex infections
#11Compositions and methods for preventing infection
#12Composition and regimen for the treatment of herpes simplex virus, herpes zoster, and herpes genitalia epidermal herpetic lesions
#13β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
#14Treatment of mucosal membranes
#15Anti-infective compositions, methods and systems for treating pathogen-induced disordered tissues
#16Therapeutic treatments using the direct application of antimicrobial metal compositions
#17Treatment of inflammatory skin conditions
#18Nucleoside analogs in combination therapy of herpes simplex infections
#19β-Cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
#20Compositions and methods for inhibiting abnormal cell growth
#21Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
#22Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
#23Treatment of humans with colloidal silver composition
#24Medicament for the treatment of viral skin and tumour diseases
#25Anti-viral compositions and methods of making and using the anti-viral compositions
#26Nanodiamond compositions and their use for drug delivery